Skip to main content
U.S. flag

An official website of the United States government

AAIC goes virtual this year: Watch for NIA online!

Eliezer Masliah
Eliezer MASLIAH,
Division of Neuroscience (DN)

NIA staff won’t need to pack their bags this month for the annual Alzheimer’s Association International Conference (AAIC) 2020, which is a free, virtual, event July 27-31. I look forward to joining dementia researchers, clinicians, advocates, and health care providers from around the world to learn about and share research discoveries, emerging technologies, and new strategies to advance discovery of treatments and preventions for Alzheimer’s disease and related dementias.

Find NIA staff in the virtual exhibit hall

You can access the virtual exhibit hall throughout the entire conference, so plan to “stop by” the NIA booth to gather information about us or schedule a meeting with NIA staff to ask questions or simply connect. Live exhibit chat hours are Monday through Thursday from 8:00-10:00 a.m. CT. The virtual event platform, including the virtual exhibit hall, will remain accessible for 30 days after the conference.

Don’t miss these events!

NIA leadership and staff are participating in several sessions. If you are interested in learning more about NIA and NIH research, funding for projects, and/or career support, be sure to add the following to your calendar:

Monday, July 27, 7:00-8:00 a.m. CT
EV or Not EV? Extracellular Propagation of AD Pathogenic Molecules and Evaluation of Brain Cell-Derived Extracellular Vesicles from Patient Plasma as EV Biomarkers

Dimitrios Kapogiannis, an investigator in NIA’s Intramural Research Program, will discuss “Plasma Extracellular Vesicles of Neuronal and Astrocytic Origins: Biomarker Carriers and Pathogenic Effectors in Alzheimer’s Disease.”

Wednesday, July 29, 3:00-4:00 p.m. CT
Vascular Contributions to Dementia: Risk Factors and Prevention Panel Discussion

As part of this panel, I will provide an update on vascular dementia research in the context of the National Plan to Address Alzheimer’s Disease.

Thursday, July 30, 1:30-1:55 p.m. CT
Raising Awareness of Alzheimer’s Clinical Trials

Melissa McGowan, outreach and education branch chief in NIA’s Office of Communications and Public Liaison, will discuss “Raising Awareness of Alzheimer’s Clinical Trials: Development of Messages Tailored to African American Caregivers and Individuals at Risk.”

Holly Massett, senior advisor on clinical research recruitment and engagement in the NIA Division of Extramural Activities (DEA), will present a poster on "Raising Awareness of Clinical Trials in Dementia: A National Survey Testing Concept Design Tailored to African American Caregivers and Individuals at Risk."

Thursday, July 30, 5:00-6:00 p.m. CT
Funding Opportunities for Postdoctoral Fellows and Junior Faculty at the National Institute on Aging

Shahrooz Vahedi, training officer, NIA DEA, and Miroslaw "Mack" Mackiewicz, program officer, NIA Division of Neuroscience (DN), will discuss training and funding opportunities for early-career researchers.

July 27-July 31, available on demand
Accompanying live session, Friday, July 31, 8:30-9:30 a.m. CT

3rd NIA-Alzheimer’s Association (AA) Symposium: Enabling Precision Medicine for Alzheimer’s Disease Through Open Science

This NIA-AA Symposium spotlights several research and translational infrastructure programs focused on open-science collaboration in the frontiers of Alzheimer’s research.

Suzana Petanceska, director, NIA DN Office for Strategic Development and Partnerships, will give the introduction. Lorenzo Refolo, chief, Translational Research Branch, NIA DN, will discuss “From Mice to Medicine: Improving the Predictive Value of Preclinical Research” and Laurie Ryan, chief, Clinical Interventions and Diagnostics Branch, NIA DN, will present “Introduction to NIA’s Alzheimer’s Clinical Trials Infrastructure and Preclinical to Clinical Drug Development Pipeline.” Other discussion topics will include:

  • Accelerating Medicines Partnership for Alzheimer’s Disease Target Discovery Program and Affiliated Consortia
  • Model Organism Development and Evaluation for Late-Onset Alzheimer’s Disease (MODEL-AD) Consortium
  • TREAT-AD Consortium
  • Translational Bioinformatics Program for Drug Repositioning and Combination Therapy Development
  • Alzheimer’s Drug Development Program
  • Alzheimer’s Clinical Trials Consortium

Friday, July 31, 11:30 a.m.-12:30 p.m. CT
NIA-Alzheimer’s Association Symposium: Developing an Applied Science of Recruitment and Retention for Alzheimer’s Disease and Related Dementias (AD/ADRD) Clinical Research

This NIA-AA Symposium will provide a global forum to help build a strong scientific foundation for the science of recruitment around AD/ADRD clinical trials. The discussion will focus on identifying opportunities to accelerate and expand existing efforts and discuss novel approaches, including building new collaborations and partnerships.

Friday, July 31, 1:00 p.m. CT
NIA-Alzheimer’s Association Symposium: IMPACT Embedded Pragmatic Clinical Trials for the Improvement of Care for People Living with Dementia and their Care Partners

Through this NIA-Alzheimer’s Association Symposium, participants will share key considerations in the design and conduct of embedded pragmatic clinical trials for persons living with dementia.

Note: Pre-recorded materials from many of the above sessions will become available on demand beginning Monday, July 27 and will be available for 30 days after the conference.

I hope you’ll take the time to check out NIA’s virtual booth and chat with NIA staff and view our presentations and posters sessions.

Want to attend? It’s not too late: AAIC registration is free and open through July 31. You can also keep up with the latest AAIC-related NIA news and info by following @NIHAging or tracking #AAIC20 on Twitter. See you online!


Submitted by Lynne Iannone on July 27, 2020

I would like to virtually attend these 2 presentations.Raising Awareness of Alzheimer’s Clinical Trials and NIA-Alzheimer’s Association Symposium: Developing an Applied Science of Recruitment and Retention for Alzheimer’s Disease and Related Dementias (AD/ADRD) Clinical Research

Add new comment

Your e-mail address will not be posted.

Plain text

  • Allowed HTML tags: <p> <br>
  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

An official website of the National Institutes of Health